Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease: A clinical consensus statement of the ESC Council on Cardiovascular Genomics, the ESC Cardiovascular Risk Collaboration, and the European Association of Preventive Cardiology
Saved in:
| Title: | Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease: A clinical consensus statement of the ESC Council on Cardiovascular Genomics, the ESC Cardiovascular Risk Collaboration, and the European Association of Preventive Cardiology |
|---|---|
| Authors: | Schunkert H; Department of Cardiology, Deutsches Herzzentrum München, Universitätsklinikum der Technischen Universität München, 80636 Munich, Lazarettstrasse 36, Germany.; Deutsches Zentrum für Herz- und Kreislauferkrankungen (DZHK), Partner Site Munich Heart Alliance, Munich, Germany., Di Angelantonio E; BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.; BHF Centre of Research Excellence, School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.; NIHR Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, UK.; Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Hinxton, UK.; Health Data Science Centre, Human Technopole, Milan, Italy., Inouye M; BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.; BHF Centre of Research Excellence, School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.; Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Hinxton, UK.; Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Australia., Patel RS; Institute of Cardiovascular Sciences, University College London, London, UK.; Barts Heart Centre, St Bartholomew's Hospital, London, UK.; National Institute of Health Research Biomedical Research Centre, University College London Hospitals, London, UK., Ripatti S; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland.; Faculty of Medicine, University of Helsinki, Finland.; Massachusetts General Hospital & Broad Institute of MIT and Harvard, MA, USA., Widen E; Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland., Sanderson SC; Public Health Genomics (PHG) Foundation, Cambridge, UK.; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.; Department of Behavioural Science and Health, University College London, London, UK., Kaski JP; Centre for Paediatric Inherited and Rare Cardiovascular Disease, UCL Institute of Cardiovascular Science, London, and Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital, London, UK., McEvoy JW; National Institute for Prevention and Cardiovascular Health, University of Galway School of Medicine, Galway, Ireland., Vardas P; University of Crete, Greece.; European Society of Cardiology Health Policy Unit, European Heart Health Institute, Brussels, Belgium., Wood A; BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; BHF Centre of Research Excellence, School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.; NIHR Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, UK.; Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Hinxton, UK.; Cambridge Centre of Artificial Intelligence in Medicine, University of Cambridge, Cambridge, UK., Aboyans V; Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT-Epidemiology of Chronic Diseases in Tropical Zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France.; Department of Cardiology, Dupuytren-2 University Hospital Center, Limoges, France., Vassiliou VS; Department of Cardiology, Norwich Medical School, University of East Anglia and Norfolk and Norwich University Hospital, Norwich, UK., Visseren FLJ; Department of Vascular Medicine, University Medical Centre Utrecht, The Netherlands., Lopes LR; Institute of Cardiovascular Sciences, University College London, London, UK.; Barts Heart Centre, St Bartholomew's Hospital, London, UK., Elliott P; Institute of Cardiovascular Sciences, University College London, London, UK., Kavousi M; Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. |
| Source: | European heart journal [Eur Heart J] 2025 Apr 15; Vol. 46 (15), pp. 1372-1383. |
| Publication Type: | Journal Article; Consensus Statement |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print Cited Medium: Internet ISSN: 1522-9645 (Electronic) Linking ISSN: 0195668X NLM ISO Abbreviation: Eur Heart J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1522-9645 |
|---|---|
| DOI: | 10.1093/eurheartj/ehae649 |
